Jeffrey Duchemin | President and Chief Executive Officer |
Corey Manchester | Vice President, Corporate Controller |
Paul Knight | Janney |
Bruce Jackson | Benchmark |
Lisa Springer | Singular Research |
Welcome to the Q3 2018 Harvard Bioscience, Incorporated Earnings Conference Call. My name is Adrian, and I’ll be your operator for today’s call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session. [Operator Instructions] Please note this conference is being recorded.